STAT3 and cancer: Research has found that RCC1 domain-containing protein 2 (HERC2) enhances the stemness of HCC cells and PD-L1-mediated immune escape, which is associated with the activation of the signal transducer and activator of transcription 3 (STAT3) pathway during the inflammation–cancer transition.